Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Ferraz-Amaro

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Medicina Clinica|January 5, 2016
[Reply]Beatriz Tejera Segura, Ivan Ferraz-Amaro
Clinical and Experimental Rheumatology|March 13, 2023
Reply to comment on: Alpha-Klotho protein in systemic lupus erythematosusIvan Ferraz-Amaro, Miguel Angel Gonzalez-Gay
Clinical and Experimental Rheumatology|August 4, 2017
Undifferentiated connective tissue disease: predictors of evolution into definite diseaseMaría García-González, Beatriz Rodríguez-Lozano, Sagrario Bustabad, et al.
Clinical and Experimental Rheumatology|March 5, 2016
Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritisBeatriz Tejera-Segura, Antonia M de Vera-González, Raquel López-Mejías, et al.
European Journal of Internal Medicine|March 22, 2023
Association between cumulative dose of hydroxychloroquine and electrocardiographic abnormalities in patients with systemic lupus erythematosusJon Zubiaur, Alba Herrero-Morant, Adrián Margarida de Castro, et al.
Clinical and Experimental Rheumatology|April 24, 2020
Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosisIvan Ferraz-Amaro, Esmeralda Delgado-Frías, Vanesa Hernández-Hernández, et al.
Clinical and Experimental Rheumatology|February 22, 2020
Reclassification into very-high cardiovascular risk after carotid ultrasound in patients with axial spondyloarthritisJavier Rueda-Gotor, Juan Carlos Quevedo-Abeledo, Alfonso Corrales, et al.
Clinical and Experimental Rheumatology|January 22, 2018
Amylin in the insulin resistance of patients with rheumatoid arthritisIvan Ferraz-Amaro, Raquel López-Mejias, Beatriz Tejera-Segura, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisJuan Carlos Quevedo-Abeledo, Íñigo Rúa-Figueroa, Hiurma Sánchez-Pérez, et al.
RMD Open|March 7, 2025
The metabolic score for insulin resistance predicts the risk of cardiovascular disease in patients with psoriatic arthritis: results from the 10-year prospective CARMA cohortMiguel A Gonzalez-Gay, Ivan Ferraz-Amaro, Santos Castañeda, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Medicina Clinica|January 5, 2016
[Reply]Beatriz Tejera Segura, Ivan Ferraz-Amaro
Clinical and Experimental Rheumatology|March 13, 2023
Reply to comment on: Alpha-Klotho protein in systemic lupus erythematosusIvan Ferraz-Amaro, Miguel Angel Gonzalez-Gay
Clinical and Experimental Rheumatology|August 4, 2017
Undifferentiated connective tissue disease: predictors of evolution into definite diseaseMaría García-González, Beatriz Rodríguez-Lozano, Sagrario Bustabad, et al.
Clinical and Experimental Rheumatology|March 5, 2016
Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritisBeatriz Tejera-Segura, Antonia M de Vera-González, Raquel López-Mejías, et al.
European Journal of Internal Medicine|March 22, 2023
Association between cumulative dose of hydroxychloroquine and electrocardiographic abnormalities in patients with systemic lupus erythematosusJon Zubiaur, Alba Herrero-Morant, Adrián Margarida de Castro, et al.
Clinical and Experimental Rheumatology|April 24, 2020
Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosisIvan Ferraz-Amaro, Esmeralda Delgado-Frías, Vanesa Hernández-Hernández, et al.
Clinical and Experimental Rheumatology|February 22, 2020
Reclassification into very-high cardiovascular risk after carotid ultrasound in patients with axial spondyloarthritisJavier Rueda-Gotor, Juan Carlos Quevedo-Abeledo, Alfonso Corrales, et al.
Clinical and Experimental Rheumatology|January 22, 2018
Amylin in the insulin resistance of patients with rheumatoid arthritisIvan Ferraz-Amaro, Raquel López-Mejias, Beatriz Tejera-Segura, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisJuan Carlos Quevedo-Abeledo, Íñigo Rúa-Figueroa, Hiurma Sánchez-Pérez, et al.
RMD Open|March 7, 2025
The metabolic score for insulin resistance predicts the risk of cardiovascular disease in patients with psoriatic arthritis: results from the 10-year prospective CARMA cohortMiguel A Gonzalez-Gay, Ivan Ferraz-Amaro, Santos Castañeda, et al.
Pageof 3